Shareholders should take the acquisition offer just announced for Canadian biopharm company Bellus H... Read More
Research Capital Corporation analyst André Uddin thinks Bellus Health (Bellus Stock Quote, Chart, N... Read More
Taking in some positive clinical results from Canadian drug company Bellus Health (Bellus Stock Quo... Read More
The global pharmaceutical and biotech industry has been getting a lot of attention over the past yea... Read More
Research Capital analyst André Uddin has revised his view on Bellus Health (Bellus Stock Quote, Cha... Read More
Research Capital Corporation analyst André Uddin has revised his view on Bellus Health (Bellus Stoc... Read More
Mackie Research analyst André Uddin reviewed the state of affairs for drug developer Bellus Health ... Read More
Negative top-line results from its Phase 2 clinical study are cause for a rating change on Bellus He... Read More
Mackie Research analyst André Uddin is holding steady with Bellus Health (Bellus Health Stock Quote... Read More
Recent shifts in the competitive landscape have Mackie Research Capital analyst André Uddin raising... Read More
After the fourth quarter and year end results from Bellus Health (Bellus Health Stock Quote, Chart T... Read More
Bellus Health (Bellus Health Stock Quote, Chart TSX:BLU) is all cashed-up to start a Phase II trial ... Read More
Clinical-stage drug company Bellus Health (Bellus Health Stock Quote, Chart: TSX:BLU) is developing ... Read More
Biopharmaceutical company Bellus Health Inc. (Bellus Health Stock Quote, Chart, News: TSX:BLU) is de... Read More
Canada’s Cashed up Tech Stocks, PART THREE. Companies Listed in the TSX, Technology, Cleantech... Read More
Share
Tweet
pin
Share